The Promise of Intranasal Esketamine as a Novel and Effective Antidepressant

JAMA Psychiatry. 2018 Feb 1;75(2):123-124. doi: 10.1001/jamapsychiatry.2017.3738.
No abstract available

Publication types

  • Comment

MeSH terms

  • Administration, Intranasal
  • Antidepressive Agents
  • Depression*
  • Depressive Disorder, Treatment-Resistant*
  • Humans

Substances

  • Antidepressive Agents